Case report describes cardiac involvement in type 3 Gaucher disease, suggesting early enzyme replacement therapy may improve outcomes.
Introduction Gaucher disease (GD) is part of the rare inherited metabolic disorder, being one of the most common lysosomal storage disorders. It is caused by a deficiency in B-glucocerebrosidase enzyme activity, which leads to the accumulation of glucosylceramide in macrophages. It is classified into three types depending on the presence of neurological manifestations: type 1 without neurological signs, type 2 with acute neurological manifestations, and type 3 with subacute/chronic neurological symptoms. It is uncommon, but cardiac involvement in the form of structural calcifications may be present in type 3. Case We present the case of a 20-year-old male patient diagnosed with severe mitro-aortic lesions. During surgery, massive mitral calcification and a small aortic annulus forced us to perform a Root-Commando operation with mechanical prostheses. The patient was diagnosed with type 3C Gaucher disease, and enzyme replacement therapy was started. Conclusion Our manuscript presents a rare case of cardiac affection of type 3C Gaucher disease. Early start of enzyme replacement therapy ensures a better outcome.
No takes yet. Share an insight, caveat, or question.
Rubio et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: